Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Novel Research in Sciences

Pharmacology of Attention-Deficit/ Hyperactivity Disorder Treatments

  • Open or CloseCassidy Bolton1 and Yashwant V Pathak1,2*

    1Taneja College of Pharmacy, University of South Florida, Tampa FL 33612

    p>2Adjunct professor , Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia

    *Corresponding author:Yashwant V Pathak, Taneja College of Pharmacy, University of South Florida, Tampa FL 33612 HYPERLINK Email: ypathak1@usf.edu

Submission: July 22, 2020;Published: September 11, 2020

Abstract

There is a significant body of research on the topic of treatments for attention-deficit/hyperactivity disorder in children, adolescents, and adults. Major pharmacological treatments include stimulants (amphetamines and methylphenidate) and non-stimulants (atomoxetine and others). There are also forms of non-pharmacological treatment, including behavioral and psychosocial therapies. Studies have demonstrated the most improvement in functioning and reduction of symptoms because of a combination of pharmacological and behavioral treatment, however on its own, medication management has proven to be significantly more effective than behavioral therapy strategies. This review covers recent trends in Treatments and Pharmacology of Attention-Deficit/Hyperactivity Disorder

Get access to the full text of this article